Micromedic Technologies / SRL Pilot
Micromedic Technologies’ CellDetect® is a staining technology used to simplify and expedite screening of women at risk of developing cervical cancer. CellDetect® offers a new standard for the screening of women at risk of developing cervical cancer. It is the only histochemical platform allowing color discrimination alongside morphological examination for differentiation between normal and cancer cells.
In this pilot, cervical specimens collected at SRL Diagnostics' pathology laboratory were analyzed using CellDetect® to boost the detection of early-stage and pre-cancer lesions. The primary goal of this pilot was to test the efficacy, utility and overall usability of CellDetect® in SRL Diagnostics' reference pathology laboratory.
February 2017 - September 2017
SRL Diagnostics, Gurgaon lab, New Delhi, India
180 patients were enrolled in the pilot
130 sets of cervical smears from women at the age range of 27-75 years were prepared.
109 were considered normal and 21 were considered suspicious with both staining methods.
This pilot demonstrated that the time spent to interpret a CellDetect® slide was significantly shorter compared to the time spent to analyze a standard Pap smear.
By reducing the time required to analyze each cervical slide, CellDetect® empowers cervical screening capabilities by generating a significant increase in overall throughput and assisting in lowering the screening burden of cervical smears.
The CellDetect® color feature was considered useful in the majority of the suspicious cases and slide interpretation was deemed simplified in most of these cases. The use of color not only adds to morphology but also adds a new dimension in interpretation of suspicious cases that helps increase the throughput and improve patient's’ diagnosis.
- The CellDetect® kit was easier to operate than the team originally thought. Remote training and support were effective and sufficient.
- The program opened the opportunity to approach the Indian market and explore the need for the product.